Research-Grade Stanozolol Injectable Overview
WIN DEPOT 50 UNIQUE PHARMA is a research-grade stanozolol depot formulation designed for comprehensive in-vitro laboratory investigations. Stanozolol is a synthetic anabolic-androgenic steroid derived from dihydrotestosterone, characterised by its C-17α methylation and unique heterocyclic modifications that distinguish its pharmacological profile from testosterone analogues. This injectable formulation provides researchers with a stable depot preparation suitable for extended analytical studies examining steroid hormone mechanisms, receptor binding kinetics, and tissue-selective androgenic activity patterns. The compound’s structural modifications result in altered binding affinity profiles across androgen receptor subtypes, making it valuable for comparative receptor pharmacology research. Our Stroid UK Shop maintains rigorous quality standards for all analytical reference materials.
Laboratory Applications and Research Contexts
Stanozolol depot formulations serve critical roles in steroid biochemistry research, particularly in studies examining anabolic-androgenic dissociation indices and tissue-specific receptor activation patterns. Researchers frequently utilise this compound to investigate hepatic metabolism pathways, examining how C-17α alkylation affects cytochrome P450 enzyme interactions and metabolic clearance rates. The depot preparation allows for sustained-release kinetic studies, enabling researchers to model long-term exposure scenarios in cell culture systems. Comparative studies between oral and injectable stanozolol formulations provide insights into bioavailability differences and first-pass metabolism effects. Additional research applications include investigating glucocorticoid receptor cross-reactivity, examining potential anti-inflammatory mechanisms, and studying effects on protein synthesis regulatory pathways. Scientists at leading institutions utilise stanozolol in steroid injection research to understand structure-activity relationships within the anabolic steroid class.
Technical Specifications and Properties
| Parameter | Specification |
|---|---|
| Active Compound | Stanozolol |
| Concentration | 50mg/mL |
| Chemical Formula | C₂₁H₃₂N₂O |
| Molecular Weight | 328.49 g/mol |
| CAS Number | 10418-03-8 |
| Formulation Type | Injectable Depot |
| Storage Requirements | Room temperature, protect from light |
| Purity Grade | Research grade |
This depot formulation utilises pharmaceutical-grade excipients to ensure consistent analytical results across experimental protocols. The 50mg/mL concentration provides optimal dilution flexibility for various research methodologies, from receptor binding assays to cell viability studies. Quality assurance protocols verify compound identity through spectroscopic analysis and confirm concentration accuracy through validated HPLC methods. Researchers studying selective androgen receptor modulators often use stanozolol as a reference standard for comparative potency assessments.
Laboratory Compliance and Research Use Statement
WIN DEPOT 50 UNIQUE PHARMA is manufactured exclusively for in-vitro research applications and analytical reference purposes. This product is not intended for human consumption, therapeutic use, or any application outside controlled laboratory environments. Researchers must maintain appropriate biosafety protocols when handling steroid compounds and ensure compliance with institutional research guidelines. The injectable formulation requires proper laboratory storage conditions and should only be utilised by qualified research personnel with appropriate training in steroid biochemistry methodologies. All experiments should follow established protocols for research peptides and compounds handling. This product is sold strictly for research purposes only and requires institutional oversight for all experimental applications involving anabolic steroid research materials.
